Adamis Pharmaceuticals reported $12.14M in Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Adamis Pharmaceuticals ADMP:US USD 12.14M 5.56M
Adma Biologics ADMA:US USD 300.56M 3.63M
Brainstorm Cell Therapeutics BCLI:US USD 13.25M 5.71M
Cara Therapeutics CARA:US USD 213.51M 13.06M
GlaxoSmithKline GSK:LN GBP 60.15B 167M
Glaxosmithkline GSK:US GBP 60.15B 167M